Keywords: Philogen, Pfizer, Dekavil, Inflammatory diseases, GlycoVaxyn, Janssen, Johnson & Johnson, Bacterial vaccine

Licensing deals for Philogen with Pfizer and GlycoVaxyn with Janssen

Article | 07 January 2013

Print This

Privately held Italian biopharma firm Philogen SpA (Siena, Italy) has granted global drugs behemoth Pfizer (NYSE:PFE) a worldwide license ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in